20 ILCS 745/1-20

Current through Public Act 103-1052
Section 20 ILCS 745/1-20 - [Section Scheduled to be Repealed 1/1/2027] Duties

The Partnership shall have the following duties:

(1) Subject to appropriation and matching private funds as provided in Section 1-25, the Partnership shall develop and direct efforts to attract companies to use existing Illinois facilities for research, development, and pre-commercialization activities. Those efforts may include, without limitation: (i) representing Illinois at biotechnology conferences; (ii) developing promotional and marketing materials in coordination with existing research facilities to encourage the use of Illinois facilities; and (iii) facilitating meetings for companies that are prospective candidates for establishing a presence in this State.
(2) Subject to appropriation and matching private funds as provided in Section 1-25, the Partnership may develop programs to encourage emerging research, development, and commercializing biotechnology companies to locate production facilities in Illinois, including, but not limited to: (i) acting as an information clearinghouse for new companies on all State programs and investment incentives; and (ii) working with local and regional economic development groups.
(3) The Partnership may provide advice and recommendations to State agencies on the administration of grant programs directed at industrial biotechnology.
(4) On or before January 31 of the next calendar year to occur after the last day of any State fiscal year in which the Partnership receives State funding, the Partnership shall submit a report to the Department describing the use of appropriated funds by the Partnership in the State fiscal year for which the funds were allocated. The report shall include, but not be limited to, marketing materials produced by the Partnership, meetings attended by members of the Partnership related to Partnership business, and the hosting of companies visiting this State.

20 ILCS 745/1-20

Added by P.A. 102-0991,§ 1-20, eff. 1/1/2023.